Menu
Recruiting NCT07512102

Comparison of Low- Versus High-Level Angle Kappa Compensation Strategies in SMILE Using the VisuMax 800: A Randomized Clinical Trial

No phase Interventional Myopia Refractive Ametropia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Apply high compensation to the Kappa angle., Apply low compensation to the Kappa angle..
Who it may be relevant to
Registry conditions: Myopia, Refractive Ametropia. Basic parameters: 18 years — 40 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The goal of this clinical trial is to compare two intraoperative kappa-angle compensation strategies during small incision lenticule extraction (SMILE) using the VisuMax 800 platform in patients with relatively large kappa-angle offsets. Angle kappa represents the difference between the visual axis and the pupil center. In patients with a large offset, pupil-centered treatment may lead to decentration of the optical zone, which can induce higher-order aberrations and affect postoperative visual quality. The VisuMax 800 system allows intraoperative adjustment of the treatment center based on the measured offset, making different compensation strategies possible. The main questions this study aims to answer are: Does low kappa-angle compensation (50%) result in lower postoperative higher-order aberrations than high compensation (100%)? Does the compensation strategy influence visual acuity, refractive outcomes, contrast sensitivity, and subjective visual quality after SMILE? Are the measurements obtained from different diagnostic devices consistent when evaluating kappa-related parameters? Researchers will compare SMILE with low compensation to SMILE with high compensation to determine which strategy provides better optical quality and visual performance. Participants will: Undergo SMILE surgery using either low or high kappa-angle compensation Complete scheduled postoperative examinations at 1 month, 3 months, and 6 months Receive measurements of visual acuity, refraction, higher-order aberrations, contrast sensitivity, and patient-reported visual outcomes Be monitored for safety outcomes and adverse events during follow-up

Detailed description

Angle kappa refers to the offset between the visual axis and the pupil center and is an important factor influencing the centration of the treatment zone during corneal refractive surgery. In patients with relatively large offsets, pupil-centered treatment may lead to decentered lenticule extraction, which can induce higher-order aberrations, especially coma, and may reduce postoperative visual quality.

Small incision lenticule extraction (SMILE) is a widely used corneal refractive procedure with good safety and predictability. The new-generation VisuMax 800 femtosecond laser system incorporates machine vision-assisted alignment, allowing the surgeon to adjust the treatment center according to the measured displacement between the corneal vertex and the pupil center. This enables intraoperative compensation based on the kappa-angle offset.

Previous studies in excimer laser surgery have evaluated different proportions of kappa-angle compensation, but prospective randomized studies in SMILE are limited, particularly in patients with relatively large offsets. In addition, the optimal amount of compensation during SMILE has not been clearly determined.

This study is a single-center, randomized, parallel-group clinical trial designed to compare two predefined compensation strategies during SMILE using the VisuMax 800 platform. Patients aged 18-40 years with stable myopia or myopic astigmatism and a kappa-related displacement of at least 0.20 mm will be enrolled and randomly assigned to one of two groups.

Participants in the low-compensation group will undergo SMILE with the treatment center shifted by 50% of the measured offset coordinates, while participants in the high-compensation group will undergo SMILE with 100% compensation of the measured offset. All surgeries will be performed using the same surgical protocol, and postoperative management will be identical in both groups.

Participants will undergo routine ophthalmic examinations before surgery and at scheduled follow-up visits after surgery. The primary evaluation will assess postoperative higher-order aberrations at 3 months. Secondary evaluations will include visual acuity, refractive outcomes, refractive stability, contrast sensitivity, patient-reported visual quality, optical zone centration, and safety outcomes. In addition, measurements obtained from different diagnostic devices will be compared to assess consistency.

The results of this study will help determine the optimal intraoperative compensation strategy for SMILE in patients with large kappa-angle offsets and may contribute to improving postoperative visual quality and refractive accuracy.

Interventions

  • Procedure Apply high compensation to the Kappa angle.
    SMILE PRO is an upgraded version/procedural designation of SMILE (Small Incision Lenticule Extraction) performed on the ZEISS VisuMax 800 femtosecond laser platform. It remains, in essence, an all-femtosecond corneal refractive procedure. Its basic principle is to use a femtosecond laser to create a lenticule within the corneal stroma together with a small incision, and then remove the lenticule through that incision, thereby reshaping the corneal curvature to correct myopia and astigmatism. In
  • Procedure Apply low compensation to the Kappa angle.
    SMILE PRO is an upgraded version/procedural designation of SMILE (Small Incision Lenticule Extraction) performed on the ZEISS VisuMax 800 femtosecond laser platform. It is essentially an all-femtosecond corneal refractive procedure. Its basic principle is to use a femtosecond laser to create a lenticule within the corneal stroma and a small incision, and then remove the lenticule through the incision, thereby reshaping the corneal curvature to correct myopia and astigmatism. In the low-level com

Primary outcome measures

  • Coma aberration [Time frame: 3 months after surgery]
Secondary outcome measures (10)
  • Higher-order aberrations [Time frame: 1 month, 3 months, and 6 months after surgery]
  • Optical zone decentration [Time frame: 3 months after surgery]
  • Visual Acuity [Time frame: 1 month, 3 months, and 6 months after surgery]
  • Manifest refraction [Time frame: 1 month, 3 months, and 6 months after surgery]
  • Refractive accuracy [Time frame: 1 month, 3 months, and 6 months after surgery]
  • Refractive stability [Time frame: 1 month to 6 months after surgery]
  • Contrast sensitivity [Time frame: 3 months after surgery]
  • Quality of Vision (QoV) score [Time frame: 3 months after surgery]
  • Patient satisfaction score [Time frame: 3 months after surgery]
  • Adverse events [Time frame: Up to 6 months after surgery]

Eligibility criteria

Inclusion criteria

  • Age range: 18 - 40 years old. Patients with stable refractive status for >= 1 year, having myopia or myopic astigmatism, with refractive power within the range of SMILE procedure.
  • Normal corneal morphology and corneal thickness meeting the surgical requirements.
  • Best corrected visual acuity (CDVA) before surgery >= 1.0.
  • The kappa angle-related offset coordinates (x, y) obtained before surgery, with the absolute value of either \|x\| or \|yl\| of any eye >= 0.20mm.
  • Voluntary to undergo SMILE surgery on the VISUMAX800 platform, understanding the random grouping scheme and signing the informed consent form.

Exclusion criteria

  • History of prior ocular surgery, significant ocular trauma, or presence of corneal or ocular diseases that may affect the safety of refractive surgery.
  • Severe systemic diseases that may affect ocular healing or surgical safety.
  • Females who are pregnant or lactating.
  • Inability to cooperate as required to complete the procedure or follow-up visits.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

China · 1 center
  • Zhongshan Ophthalmic Center — Guangzhou

Publications

  • Doostparast A, Ghandhari M, Rastegar M, Khosronejad AH, Ghandhari M, Eslampoor A. Distribution and inter-device agreement of chord mu/alpha lengths and axes between Pentacam HR, Sirius, and IOLMaster 700. Photodiagnosis Photodyn Ther. 2025 Dec;56:105275. doi: 10.1016/j.pdpdt.2025.105275. Epub 2025 Nov 6. PMID 41205666
  • Shao T, Wang Y, Ng ALK, Chan TCY, Hao W, Zhang J, Cheng GPM, Jhanji V. The Effect of Intraoperative Angle Kappa Adjustment on Higher-Order Aberrations Before and After Small Incision Lenticule Extraction. Cornea. 2020 May;39(5):609-614. doi: 10.1097/ICO.0000000000002274. PMID 32040010
  • Lai X, Liu X, Zeng T, Huang Y, Yang X. Comparison of visual outcomes and optical aberrations after SMILE with intraoperative Kappa angle adjustments between small and large Kappa angles. Sci Rep. 2024 Jun 24;14(1):14551. doi: 10.1038/s41598-024-65366-w. PMID 38914606
  • Deng M, Zhou D, Li M, Shi Y, Sun L, Zou J, Ma X. Evaluation of corneal asymmetry and higher-order aberrations after small incision lenticule extraction for moderate and high myopia. Int Ophthalmol. 2025 Jun 1;45(1):218. doi: 10.1007/s10792-025-03576-5. PMID 40451982
  • Vingopoulos F, Zisimopoulos A, Kanellopoulos AJ. Comparison of effective corneal refractive centration to the visual axis: LASIK vs SMILE, a contralateral eye digitized comparison of the postoperative result. J Cataract Refract Surg. 2021 Dec 1;47(12):1511-1518. doi: 10.1097/j.jcrs.0000000000000687. PMID 34074993
  • McAlinden C, Pesudovs K, Moore JE. The development of an instrument to measure quality of vision: the Quality of Vision (QoV) questionnaire. Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5537-45. doi: 10.1167/iovs.10-5341. Epub 2010 May 26. PMID 20505205
  • Chang JS, Law AK, Ng JC, Chan VK. Comparison of refractive and visual outcomes with centration points 80% and 100% from pupil center toward the coaxially sighted corneal light reflex. J Cataract Refract Surg. 2016 Mar;42(3):412-9. doi: 10.1016/j.jcrs.2015.09.030. PMID 27063522

Identifiers

NCT: NCT07512102 · IIT2025193

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗